| [1] |
陈丽华，张美玲，钟鸿斌，等. 慢性肾脏病与肠道菌群相关性研究进展概述[J]. 临床肾脏病杂志，2021, 21(1): 74-78.
|
| [2] |
祝宇星，巴应贵. 慢性肾脏病与心血管疾病关系的研究进展[J]. 临床肾脏病杂志，2019, 19(2): 145-148.
|
| [3] |
黄玉红，王洁. 慢性肾脏病所致微炎症状态的研究进展[J]. 右江民族医学院学报，2021, 43(1): 128-133.
|
| [4] |
Corden B, Adami E, Sweeney M, et al. IL-11 in cardiac and renal fibrosis: late to the party but a central player [J]. Br J Pharmacol, 2020, 177(8): 1695-1708.
|
| [5] |
Garbers C, Scheller J. Interleukin-6 and interleukin-11: same same but different [J]. Biol Chem, 2013, 394(9): 1145-1161.
|
| [6] |
潘德燊，李登，邵怡. 白细胞介素-11对肿瘤促进作用的研究进展[J]. 上海交通大学学报(医学版), 2020, 40(4): 548-553.
|
| [7] |
Bigaeva E, Gore E, Simon E, et al. Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices [J]. Arch Toxicol, 2019, 93(12): 3549-3583.
|
| [8] |
Wu F, Zhao Y, Shao Q, et al. Ameliorative effects of osthole on experimental renal fibrosis in vivo and in vitro by inhibiting IL-11/ERK1/2 signaling [J]. Front Pharmacol, 2021, 12: 646331.
|
| [9] |
Gu YY, Liu XS, Huang XR, et al. TGF-β in renal fibrosis: triumphs and challenges [J]. Future Med Chem, 2020, 12(9): 853-866.
|
| [10] |
Schafer S, Viswanathan S, Widjaja AA, et al. IL-11 is a crucial determinant of cardiovascular fibrosis [J]. Nature, 2017, 552(7683): 110-115.
|
| [11] |
郭帅，方敬，陈志强. TGF-β1介导的Smad和ERK信号通路在肾纤维化中的研究进展 [J]. 中国免疫学杂志，2022, 38(6): 766-770.
|
| [12] |
Chien JW, Chen WL, Tsui YG, et al. Daily urinary interleukin-11 excretion correlated with proteinuria in IgA nephropathy and lupus nephritis [J]. Pediatr Nephrol, 2006, 21(4): 490-496.
|
| [13] |
郝娜，杨洪涛. JAK/STATs信号通路在慢性肾脏病领域作用机制的研究进展[J]. 中国中西医结合肾病杂志，2019, 20(7): 642-644.
|
| [14] |
张雪琴，张晶晶，郑笑，等. 血浆白细胞介素-6对慢性肾脏病预后的影响[J]. 新疆医学，2018, 48(3): 241-244.
|
| [15] |
徐雅虹，蒋茜，王雅楠，等. 血清白细胞介素-6水平在慢性肾脏病病人中的变化及与糖尿病的相关性研究[J]. 蚌埠医学院学报，2017, 42(6): 725-727, 731.
|
| [16] |
解吉来，陈道桢，王家俊. 白细胞介素-11及其受体在泌尿生殖系肿瘤的研究进展 [J]. 检验医学与临床，2016, 13(4): 554-556.
|
| [17] |
Cook SA, Schafer S. Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation [J]. Annu Rev Med, 2020, 71: 263-276.
|
| [18] |
李亚琴. 白细胞介素-11(IL-11)促进肾脏纤维化的机制研究及含笑内酯衍生物DMAMCL的干预研究[D]. 广州：南方医科大学，2021.
|
| [19] |
张玉敏，韩素桂，刘启为，等. 白细胞介素-11在小鼠脑缺血再灌注损伤中的保护作用及其机制[J]. 免疫学杂志，2021, 37(2): 134-139.
|
| [20] |
Ye J, Wang Z, Ye D, et al. Increased interleukin-11 levels are correlated with cardiac events in patients with chronic heart failure [J]. Mediators Inflamm, 2019, 2019: 1575410.
|
| [21] |
张银玲. IL-6、IL-11、BNP、肌酐与慢性心衰患者预后相关性分析[D]. 乌鲁木齐：新疆医科大学，2019.
|
| [22] |
Corden B, Lim WW, Song W, et al. Therapeutic targeting of interleukin-11 signalling reduces pressure overload-induced cardiac fibrosis in mice [J]. J Cardiovasc Transl Res, 2021, 14(2): 222-228.
|
| [23] |
Kespohl B, Schumertl T, Bertrand J, et al. The cytokine interleukin-11 crucially links bone formation, remodeling and resorption [J]. Cytokine Growth Factor Rev, 2021, 60: 18-27.
|
| [24] |
程海涛，张晓暄，李银辉. 肾性骨病发病机制研究及进展[J]. 中国骨质疏松志，2020, 26(10): 1550-1554.
|
| [25] |
Kuriwaka-Kido R, Kido S, Miyatani Y, et al. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess [J]. Endocrinology, 2013, 154(3): 1156-1167.
|
| [26] |
廖志波，张运强，廖学渊，等. 肾性继发性甲状旁腺功能亢进对患者认知功能的影响[J]. 中国医学创新，2020, 17(34): 127-130.
|
| [27] |
Menendez-Castro C, Cordasic N, Dambietz T, et al. Correlations between interleukin-11 expression and hypertensive kidney injury in a rat model of renovascular hypertension [J]. Am J Hypertens, 2020, 33(4): 331-340.
|
| [28] |
叶枝秀，吴克义，唐朝亮，等. 右美托咪定对高血压脑出血患者围术期血清IL-6和IL-11的表达及神经功能的影响[J]. 立体定向和功能性神经外科杂志，2020, 33(6): 359-362.
|